A carregar...

Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis

Dementia affects more than 40 million people worldwide. When it is accompanied by psychosis, symptom management is especially challenging. Although no drug has been approved by the US Food and Drug Administration (FDA) for psychosis in patients with dementia, atypical antipsychotics are used off-lab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ismaeel Yunusa, Marie Line El Helou, Saud Alsahali
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020-02-01
Colecção:Frontiers in Pharmacology
Assuntos:
Acesso em linha:https://www.frontiersin.org/article/10.3389/fphar.2020.00087/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!